Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Lyve1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYVE1 mRNA | CTD | PMID:36331819 | Lyve1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of LYVE1 mRNA] | CTD | PMID:22206623 | Lyve1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of LYVE1 mRNA | CTD | PMID:22206623 | Lyve1 | Rat | 1-octadec-9-enoylglycero-3-phosphate | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | lysophosphatidic acid results in increased expression of LYVE1 mRNA; lysophosphatidic acid results in increased expression more ... | CTD | PMID:18642114 | Lyve1 | Rat | 1-octadec-9-enoylglycero-3-phosphate | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | 3-(4-dimethylamino-naphthalen-1-ylmethylene)-1,3-dihydro-indol-2-one inhibits the reaction [lysophosphatidic acid results in increased expression of LYVE1 protein] | CTD | PMID:18642114 | Lyve1 | Rat | 17beta-estradiol | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Estradiol results in increased expression of LYVE1 mRNA | CTD | PMID:19484750 | Lyve1 | Rat | 17beta-estradiol | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | Estradiol affects the expression of LYVE1 mRNA | CTD | PMID:39298647 | Lyve1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYVE1 mRNA | CTD | PMID:21570461 | Lyve1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYVE1 mRNA | CTD | PMID:34747641 | Lyve1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LYVE1 mRNA | CTD | PMID:32109520 | Lyve1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of LYVE1 mRNA | CTD | PMID:38648751 | Lyve1 | Rat | 2-palmitoylglycerol | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of LYVE1 mRNA | CTD | PMID:37199045 | Lyve1 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of LYVE1 mRNA | CTD | PMID:19162173 | Lyve1 | Rat | 4,4'-diaminodiphenylmethane | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of XLKD1 mRNA | CTD | PMID:18648102 | Lyve1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of LYVE1 mRNA | CTD | PMID:30951980|PMID:39298647 | Lyve1 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of LYVE1 mRNA | CTD | PMID:28973697 | Lyve1 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of LYVE1 mRNA | CTD | PMID:28973697 | Lyve1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of LYVE1 mRNA | CTD | PMID:24780913|PMID:25825206 | Lyve1 | Rat | 7,12-dimethyltetraphene | decreases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LYVE1 mRNA | CTD | PMID:19480007 | Lyve1 | Rat | 8-Br-cAMP | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XLKD1 mRNA | CTD | PMID:22079614 | Lyve1 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of LYVE1 mRNA | CTD | PMID:31881176 | Lyve1 | Rat | aflatoxin B1 | increases methylation | ISO | LYVE1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LYVE1 gene | CTD | PMID:27153756 | Lyve1 | Rat | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LYVE1 more ... | CTD | PMID:37999580 | Lyve1 | Rat | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LYVE1 more ... | CTD | PMID:37999580 | Lyve1 | Rat | arsenous acid | decreases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of LYVE1 mRNA; Arsenic Trioxide results in decreased expression more ... | CTD | PMID:38275666 | Lyve1 | Rat | benzo[a]pyrene | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of XLKD1 mRNA | CTD | PMID:19770486 | Lyve1 | Rat | benzo[a]pyrene | increases methylation | ISO | LYVE1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LYVE1 exon | CTD | PMID:27901495 | Lyve1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Lyve1 | Rat | benzo[a]pyrene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of LYVE1 mRNA | CTD | PMID:21569818|PMID:21964900|PMID:22610609 | Lyve1 | Rat | benzo[a]pyrene | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of LYVE1 mRNA | CTD | PMID:20106945|PMID:21632981 | Lyve1 | Rat | benzo[b]fluoranthene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of LYVE1 mRNA | CTD | PMID:26377693 | Lyve1 | Rat | benzo[b]fluoranthene | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Lyve1 | Rat | bexarotene | multiple interactions | EXP | | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of XLKD1 mRNA | CTD | PMID:17630414 | Lyve1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LYVE1 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:34947998|PMID:38750585 | Lyve1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LYVE1 mRNA | CTD | PMID:34973380 | Lyve1 | Rat | bisphenol A | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LYVE1 mRNA | CTD | PMID:30245210|PMID:32156529|PMID:38701888|PMID:39742910 | Lyve1 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of LYVE1 gene | CTD | PMID:28505145 | Lyve1 | Rat | bisphenol F | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of LYVE1 mRNA | CTD | PMID:38685157 | Lyve1 | Rat | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of LYVE1 mRNA | CTD | PMID:24136188 | Lyve1 | Rat | buta-1,3-diene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | 1,3-butadiene results in increased expression of LYVE1 mRNA | CTD | PMID:29038090 | Lyve1 | Rat | Butylbenzyl phthalate | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of LYVE1 mRNA | CTD | PMID:28392331 | Lyve1 | Rat | cadmium atom | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LYVE1 more ... | CTD | PMID:37325564 | Lyve1 | Rat | cadmium atom | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of LYVE1 mRNA; Cadmium results in increased expression of LYVE1 more ... | CTD | PMID:33866181 | Lyve1 | Rat | cadmium dichloride | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LYVE1 more ... | CTD | PMID:37325564 | Lyve1 | Rat | cantharidin | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of LYVE1 mRNA | CTD | PMID:36907384 | Lyve1 | Rat | carbon nanotube | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | Nanotubes, Carbon affects the expression of LYVE1 mRNA; Nanotubes, Carbon analog affects the expression of more ... | CTD | PMID:23845593|PMID:25554681 | Lyve1 | Rat | carbon nanotube | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of LYVE1 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25620056 | Lyve1 | Rat | carnosic acid | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | salvin results in increased expression of LYVE1 protein | CTD | PMID:35926579 | Lyve1 | Rat | CGP 52608 | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to XLKD1 gene] | CTD | PMID:28238834 | Lyve1 | Rat | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of LYVE1 mRNA | CTD | PMID:23125180 | Lyve1 | Rat | chloroprene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Chloroprene results in increased expression of LYVE1 mRNA | CTD | PMID:23125180 | Lyve1 | Rat | choline | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lyve1 | Rat | chrysene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | chrysene results in increased expression of LYVE1 mRNA | CTD | PMID:26377693 | Lyve1 | Rat | chrysene | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Lyve1 | Rat | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of XLKD1 mRNA | CTD | PMID:17602206 | Lyve1 | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of LYVE1 mRNA | CTD | PMID:30556269 | Lyve1 | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of LYVE1 mRNA | CTD | PMID:30556269 | Lyve1 | Rat | copper(II) sulfate | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of LYVE1 mRNA | CTD | PMID:19549813 | Lyve1 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of LYVE1 mRNA | CTD | PMID:27523638 | Lyve1 | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of LYVE1 mRNA | CTD | PMID:23914054 | Lyve1 | Rat | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of LYVE1 mRNA | CTD | PMID:34014027 | Lyve1 | Rat | diarsenic trioxide | decreases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of LYVE1 mRNA; Arsenic Trioxide results in decreased expression more ... | CTD | PMID:38275666 | Lyve1 | Rat | dibenz[a,h]anthracene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of LYVE1 mRNA | CTD | PMID:26377693 | Lyve1 | Rat | dibutyl phthalate | affects expression | EXP | | 6480464 | Dibutyl Phthalate affects the expression of LYVE1 mRNA | CTD | PMID:30934153 | Lyve1 | Rat | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of LYVE1 mRNA | CTD | PMID:21658437 | Lyve1 | Rat | dioxygen | decreases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of LYVE1 mRNA | CTD | PMID:26516004 | Lyve1 | Rat | dioxygen | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYVE1 mRNA | CTD | PMID:30529165 | Lyve1 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of LYVE1 mRNA | CTD | PMID:25152437 | Lyve1 | Rat | divanadium pentaoxide | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | vanadium pentoxide affects the expression of LYVE1 mRNA | CTD | PMID:26210822 | Lyve1 | Rat | dorsomorphin | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Lyve1 | Rat | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of LYVE1 mRNA | CTD | PMID:19915844 | Lyve1 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of LYVE1 mRNA] | CTD | PMID:19915844 | Lyve1 | Rat | epoxiconazole | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of LYVE1 mRNA | CTD | PMID:35436446 | Lyve1 | Rat | folic acid | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992|PMID:22206623 | Lyve1 | Rat | folic acid | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of LYVE1 mRNA | CTD | PMID:25629700 | Lyve1 | Rat | gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Hexachlorocyclohexane results in increased expression of XLKD1 mRNA | CTD | PMID:17785943 | Lyve1 | Rat | isoprenaline | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of LYVE1 mRNA | CTD | PMID:20003209 | Lyve1 | Rat | L-methionine | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Lyve1 | Rat | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of LYVE1 mRNA | CTD | PMID:22641619 | Lyve1 | Rat | lipopolysaccharide | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of LYVE1 mRNA | CTD | PMID:27339419 | Lyve1 | Rat | lipopolysaccharide | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYVE1 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Lyve1 | Rat | medroxyprogesterone acetate | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Medroxyprogesterone Acetate results in increased expression of XLKD1 mRNA | CTD | PMID:20843944 | Lyve1 | Rat | mercury dibromide | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of LYVE1 mRNA | CTD | PMID:26272509 | Lyve1 | Rat | mercury dibromide | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Lyve1 | Rat | mifepristone | decreases expression | EXP | | 6480464 | Mifepristone results in decreased expression of LYVE1 mRNA | CTD | PMID:25972201 | Lyve1 | Rat | monocrotaline | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Monocrotaline results in decreased expression of LYVE1 protein | CTD | PMID:31470032 | Lyve1 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of XLKD1 mRNA | CTD | PMID:17602206 | Lyve1 | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of LYVE1 mRNA | CTD | PMID:24136188 | Lyve1 | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of LYVE1 mRNA | CTD | PMID:24136188 | Lyve1 | Rat | okadaic acid | increases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of LYVE1 mRNA | CTD | PMID:38832940 | Lyve1 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LYVE1 mRNA | CTD | PMID:25729387 | Lyve1 | Rat | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of LYVE1 mRNA | CTD | PMID:25729387 | Lyve1 | Rat | ozone | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Ozone results in increased expression of XLKD1 mRNA | CTD | PMID:17095637 | Lyve1 | Rat | ozone | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | Lyve1 | Rat | paracetamol | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of LYVE1 mRNA | CTD | PMID:17562736 | Lyve1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of LYVE1 mRNA | CTD | PMID:33387578 | Lyve1 | Rat | paracetamol | decreases expression | ISO | LYVE1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of LYVE1 mRNA | CTD | PMID:21420995 | Lyve1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LYVE1 mRNA | CTD | PMID:36331819 | Lyve1 | Rat | phenobarbital | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LYVE1 mRNA] | CTD | PMID:19482888 | Lyve1 | Rat | phenobarbital | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of LYVE1 mRNA | CTD | PMID:19270015|PMID:19482888 | Lyve1 | Rat | pirinixic acid | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Lyve1 | Rat | pirinixic acid | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of LYVE1 mRNA; pirinixic acid results in increased expression more ... | CTD | PMID:18301758|PMID:18445702|PMID:23811191 | Lyve1 | Rat | pirinixic acid | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of LYVE1 mRNA | CTD | PMID:25270620 | Lyve1 | Rat | potassium dichromate | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of XLKD1 mRNA | CTD | PMID:23608068 | Lyve1 | Rat | razoxane | multiple interactions | EXP | | 6480464 | Razoxane inhibits the reaction [Doxorubicin results in increased expression of LYVE1 mRNA] | CTD | PMID:19915844 | Lyve1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LYVE1 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Lyve1 | Rat | SB 431542 | multiple interactions | ISO | LYVE1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Lyve1 | Rat | Senkirkine | increases expression | EXP | | 6480464 | senkirkine results in increased expression of LYVE1 mRNA | CTD | PMID:32419051 | Lyve1 | Rat | silicon dioxide | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of LYVE1 mRNA | CTD | PMID:23221170 | Lyve1 | Rat | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of LYVE1 protein | CTD | PMID:37244296 | Lyve1 | Rat | sodium arsenate | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of LYVE1 mRNA | CTD | PMID:39847705 | Lyve1 | Rat | sodium arsenite | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LYVE1 more ... | CTD | PMID:37999580 | Lyve1 | Rat | tacrolimus hydrate | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Tacrolimus results in decreased expression of LYVE1 mRNA | CTD | PMID:25270620 | Lyve1 | Rat | tamoxifen | affects expression | ISO | Lyve1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of XLKD1 mRNA | CTD | PMID:20937368 | Lyve1 | Rat | tamoxifen | multiple interactions | EXP | | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of XLKD1 mRNA | CTD | PMID:17630414 | Lyve1 | Rat | tetrachloroethene | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of LYVE1 mRNA | CTD | PMID:28973375 | Lyve1 | Rat | tetrachloromethane | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of LYVE1 mRNA | CTD | PMID:27339419|PMID:31919559 | Lyve1 | Rat | tetraphene | multiple interactions | ISO | Lyve1 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... | CTD | PMID:27858113 | Lyve1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LYVE1 mRNA | CTD | PMID:34492290 | Lyve1 | Rat | titanium dioxide | decreases expression | ISO | Lyve1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LYVE1 mRNA | CTD | PMID:23557971|PMID:35295148 | Lyve1 | Rat | titanium dioxide | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of XLKD1 mRNA | CTD | PMID:27760801 | Lyve1 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of LYVE1 mRNA | CTD | PMID:25729387 | Lyve1 | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of LYVE1 mRNA | CTD | PMID:25729387 | Lyve1 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of LYVE1 mRNA | CTD | PMID:33387578 | Lyve1 | Rat | triptonide | increases expression | ISO | Lyve1 (Mus musculus) | 6480464 | triptonide results in increased expression of LYVE1 mRNA | CTD | PMID:33045310 | Lyve1 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of XLKD1 mRNA | CTD | PMID:19015723 | |






















